These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 25142599

  • 1. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

  • 2. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 3. Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.
    Whitbeck JC, Huang ZY, Cairns TM, Gallagher JR, Lou H, Ponce-de-Leon M, Belshe RB, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Jul; 88(14):7786-95. PubMed ID: 24789783
    [Abstract] [Full Text] [Related]

  • 4. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
    Komala Sari T, Gianopulos KA, Nicola AV.
    J Virol; 2020 Feb 14; 94(5):. PubMed ID: 31826995
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
    Cairns TM, Fontana J, Huang ZY, Whitbeck JC, Atanasiu D, Rao S, Shelly SS, Lou H, Ponce de Leon M, Steven AC, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Mar 14; 88(5):2677-89. PubMed ID: 24352457
    [Abstract] [Full Text] [Related]

  • 6. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM.
    J Virol; 2008 Jul 14; 82(14):6935-41. PubMed ID: 18480440
    [Abstract] [Full Text] [Related]

  • 7. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 14; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT, Marshall JD, Dorwart MR, Heeke DS, Rao E, Tummala P, Yu L, Cohen GH, Eisenberg RJ, Sloan DD.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228587
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J, Szczesiul MS, Marlin SD, Levine M.
    Virology; 1983 Apr 15; 126(1):1-18. PubMed ID: 6189286
    [Abstract] [Full Text] [Related]

  • 10. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors.
    Atanasiu D, Cairns TM, Whitbeck JC, Saw WT, Rao S, Eisenberg RJ, Cohen GH.
    mBio; 2013 Feb 26; 4(2):. PubMed ID: 23443004
    [Abstract] [Full Text] [Related]

  • 11. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR, Kühn JE, Braun RW.
    J Med Virol; 1989 Jan 26; 27(1):59-65. PubMed ID: 2466100
    [Abstract] [Full Text] [Related]

  • 12. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
    Atanasiu D, Saw WT, Lazear E, Whitbeck JC, Cairns TM, Lou H, Eisenberg RJ, Cohen GH.
    J Virol; 2018 Dec 15; 92(24):. PubMed ID: 30282715
    [Abstract] [Full Text] [Related]

  • 13. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R, Mou SW, Zaia JA.
    J Med Virol; 1985 Jun 15; 16(2):147-62. PubMed ID: 2409225
    [Abstract] [Full Text] [Related]

  • 14. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
    Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM.
    PLoS Pathog; 2018 May 15; 14(5):e1007095. PubMed ID: 29791513
    [Abstract] [Full Text] [Related]

  • 15. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T, Ponce-de-Leon M, Jiang H, Dubin G, Lubinski JM, Eisenberg RJ, Cohen GH.
    J Virol; 1998 Jan 15; 72(1):65-72. PubMed ID: 9420201
    [Abstract] [Full Text] [Related]

  • 16. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E, Castelli M, Diotti RA, Amato V, Burioni R, Clementi M, Ambrosi A, Mancini N, Clementi N.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30867302
    [Abstract] [Full Text] [Related]

  • 17. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC, Marlin SD, Levine M, Glorioso J.
    J Virol; 1983 Feb 01; 45(2):672-82. PubMed ID: 6187935
    [Abstract] [Full Text] [Related]

  • 18. Using Split Luciferase Assay and anti-HSV Glycoprotein Monoclonal Antibodies to Predict a Functional Binding Site Between gD and gH/gL.
    Atanasiu D, Saw WT, Cairns TM, Eisenberg RJ, Cohen GH.
    J Virol; 2021 Mar 25; 95(8):. PubMed ID: 33504603
    [Abstract] [Full Text] [Related]

  • 19. Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.
    Cohen GH, Dietzschold B, Ponce de Leon M, Long D, Golub E, Varrichio A, Pereira L, Eisenberg RJ.
    J Virol; 1984 Jan 25; 49(1):102-8. PubMed ID: 6197535
    [Abstract] [Full Text] [Related]

  • 20. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K, Namazue J, Campo-Vera H, Ogino T, Yamanishi K.
    Virology; 1986 Feb 25; 149(1):74-82. PubMed ID: 2418583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.